Ebola Threat Prompts EU To Focus On Adaptive Licensing
This article was originally published in The Pink Sheet Daily
Executive Summary
The spread of Ebola to Europe is prompting regulators and industry to explore in more detail adaptive licensing pathways to speed access to potentially life-saving drugs.